Safinamide 100mg Tablets

Safinamide 100mg is a selective MAO-B inhibitor added to levodopa-based treatment for Parkinson's disease when motor fluctuations occur. It helps reduce periods when the effect of levodopa wears off.
Take once daily at a consistent time, with or without food, as part of the established levodopa regimen. Dose selection depends on response, liver function and interacting medicines.
Reversible inhibition of monoamine oxidase B slows dopamine breakdown; modulation of sodium channels and glutamate release may also contribute.
Dyskinesia, nausea, insomnia, dizziness and falls may occur.
Tell your doctor if you take antidepressants or other serotonergic medicines, another MAO inhibitor, an opioid or a decongestant/stimulant. Severe liver impairment is a contraindication. Increased involuntary movements or hallucinations may require adjustment of the overall Parkinson's treatment.
Can increase useful motor-control time and reduce wearing-off periods.
No. It is an add-on to a levodopa-based regimen.
It is the return of motor symptoms before the next levodopa dose takes effect.
Yes. Greater dopaminergic activity may worsen dyskinesia and require regimen adjustment.
No. The prescriber must manage incompatible combinations and washout periods.
Avoid dextromethorphan-containing cough suppressants while taking safinamide unless the specialist has specifically reviewed the combination. Interactions can cause serious changes in behaviour or nervous-system effects. Cold remedies containing pseudoephedrine or ephedrine can also raise blood pressure.
A strict low-tyramine diet is not routinely required at the recommended 50mg or 100mg daily dose. Avoid foods with very high tyramine content, such as large amounts of strongly aged cheese, because they can cause a dangerous rise in blood pressure.
Yes. Moderate impairment limits dosing and severe impairment makes use unsuitable.
Yes. They can reflect dopaminergic adverse effects and need assessment.
MAO-B: an enzyme involved in dopamine breakdown. Off time: a period of reduced response to Parkinson's treatment. Dyskinesia: involuntary movement.; AR: Safinamide 100mg أقراص; FR: Safinamide 100mg comprimés; PT: Safinamide 100mg comprimidos; ES: Safinamide 100mg comprimidos; RU: Safinamide 100mg таблетки; ID: Safinamide 100mg tablet; VI: Safinamide 100mg viên nén; MS: Safinamide 100mg tablet; TL: Safinamide 100mg tableta; ZH-SG: Safinamide 100mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Safinamide 100mg Tablets under Neuro Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Safinamide 100mg Tablets